Mice lacking TAAR1 display higher VTA neuron firing rates [15,20,21] and heightened behavioural sensitivity to psychostimulants [15,16,18,22], suggesting that pharmacological TAAR1 activation might be beneficial for tackling schizophrenia. The gene discussed is TAAR1; the disease is schizophrenia.